Invention Grant
- Patent Title: Oral administration of a calcitonin
- Patent Title (中): 口服降钙素
-
Application No.: US12529371Application Date: 2008-02-29
-
Publication No.: US08410052B2Publication Date: 2013-04-02
- Inventor: Yatindra Joshi
- Applicant: Yatindra Joshi
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Dilworth & Barrese, LLP
- Agent Ann R. Pokalsky, Esq.
- International Application: PCT/US2008/055399 WO 20080229
- International Announcement: WO2008/109385 WO 20080912
- Main IPC: A61K38/23
- IPC: A61K38/23 ; A61K31/195 ; C07C229/00 ; C07K14/585
Abstract:
The invention is directed to a method of administering pharmaceutical compositions comprising peptide drugs such as a calcitonin in combination with one or more oral delivery agents, together with an amount of a liquid, and method of treatment of disorders responsive to the action of peptide drugs such as a calcitonin employing such method of administration so as to enhance the oral bioavailability of a calcitonin. The methods of the invention increase the oral absorption and systemic bioavailability of peptide drugs, such as a calcitonin.
Public/Granted literature
- US20100210526A1 ORAL ADMINISTRATION OF A CALCITONIN Public/Granted day:2010-08-19
Information query
IPC分类:
